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Abstract
Introduction: In the human brain, there are at least as many astrocytes as neurons. Astrocytes are known to modulate
neuronal function in several ways. Thus, they may also contribute to cerebral insulin actions. Therefore, we examined
whether primary human astrocytes are insulin-responsive and whether their metabolic functions are affected by the
hormone.
Methods: Commercially available Normal Human Astrocytes were grown in the recommended medium. Major players in
the insulin signaling pathway were detected by real-time RT-PCR and Western blotting. Phosphorylation events were
detected by phospho-specific antibodies. Glucose uptake and glycogen synthesis were assessed using radio-labeled
glucose. Glycogen content was assessed by histochemistry. Lactate levels were measured enzymatically. Cell proliferation
was assessed by WST-1 assay.
Results: We detected expression of key proteins for insulin signaling, such as insulin receptor b-subunit, insulin receptor
substrat-1, Akt/protein kinase B and glycogen synthase kinase 3, in human astrocytes. Akt was phosphorylated and PI-3
kinase activity increased following insulin stimulation in a dose-dependent manner. Neither increased glucose uptake nor
lactate secretion after insulin stimulation could be evidenced in this cell type. However, we found increased insulin-
dependent glucose incorporation into glycogen. Furthermore, cell numbers increased dose-dependently upon insulin
treatment.
Discussion: This study demonstrated that human astrocytes are insulin-responsive at the molecular level. We identified
glycogen synthesis and cell proliferation as biological responses of insulin signaling in these brain cells. Hence, this cell type
may contribute to the effects of insulin in the human brain.
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Introduction
It was known for many years, that the insulin receptor is widely
expressed throughout the central nervous system (CNS) [1].
Despite that, the brain was still considered to be a mostly insulin-
independent organ, since glucose uptake is not significantly
stimulated by insulin [2]. However, in the last years, evidence
for an important role of this hormone in various brain functions
emerged [3,4]. Among others, central insulin actions were found
to be involved in the regulation of body weight and food intake
[4], in the processing of food-related stimuli [5] as well as in
memory [6]. Many of these studies were done in vivo without
knowing the responsible cell type for insulin’s actions; most of the
in vitro work focused on specific neuron subpopulations.
However, besides neurons, there are many other cell types
within the brain that may potentially contribute to the function of
the whole organ [7]. Indeed, there are at least as many glial cells as
neurons [8]. Among these, astrocytes are very interesting from a
metabolic point of view: they take up glucose and store energy as
glycogen. Even if the astrocytes’ glycogen content is low compared
to ‘classical’ glycogen storage organs such as liver and skeletal
muscle, it is of great importance for neuronal function [9].
Further on, astrocytes release lactate, which may be taken up by
neurons as an energy source in times of need, i.e. during neuronal
activity or in hypoglycemia [9–11]. However, there is still debate
about the significance of this lactate shuttling from astrocytes
towards neurons in vivo [11–13].
Astrocytes are also part of the blood-brain barrier [14] and exert a
pivotal role in the regulation of cerebral blood flow and thus contribute
to the regulation of neurons’ supply of nutrients and oxygen [15].
Furthermore, these cells take up and release various neuro-
transmitters, thereby modulating and terminating the action of
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cells [16].
More globally, astrocytes were recently shown to be involved
in a brain function that is also influenced by insulin: memory
formation [17].
On a cellular level, astrocyte-enriched cultures from rodents were
shown to form glycogen after stimulation with very high concentra-
tions of insulin [18–20]. Literature on the issue whether insulin
additionally stimulates glucose uptake into astrocytes is inconsistent
[20,21]. Furthermore, increased cell growth in response to high
insulin levels was demonstrated in rodent astrocyte-enriched cultures
[19]. Recently, a possible role of the insulin signaling cascade for the
regulation of glutamate transporter 1, an important molecule for
glutamate uptake into astrocytes, has been demonstrated [22].
However, most of these functions were detected in rodent
astrocytes. Recently, fundamental differences between rodent and
human astrocytes were reported (e.g. in size, structural complexity
and diversity, kinetics of activation) [23]. Oberheim et al.
suggested that these differences between astrocytes from rodent
vs. human origin may even explain some of the general differences
between mice and men [23]. Thus, findings in rodent astrocytes
can not generally be transferred to humans.
The aim of this study was, hence, to analyze in human primary
astrocytes whether insulin signaling occurs, and if so, whether
metabolic functions are influenced by the hormone.
Results
First, we examined the mRNA expression of major insulin
signaling molecules in human astrocytes in comparison to human
myotubes and human adipocytes: Astrocytes express insulin
receptor in similar amounts as myotubes (figure 1 A). Roughly,
two thirds of astrocytes’ insulin receptors are isoform A and
around one third is isoform B (figure 2 A). Expression levels of
insulin receptor substrate (IRS)-1 as well as IRS-2 were
significantly higher in astrocytes than in the other cell types
(figures 1 B and C). Glucose transporter (GLUT) 1 mRNA was
found in significantly greater amounts in astrocytes than in the
Figure 1. mRNA expression in human astrocytes (black bars) in comparison to human myotubes (light grey bars) and human
adipocytes (dark grey bars). (A) Insulin receptor, (B) IRS-1, (C) IRS-2, (D) GLUT1, (E) GLUT3, (F) GLUT4. mRNA expression was normalized for mRNA
of the housekeeping gene Rps13. Bars represent means + SEM. N=3. There were significant differences between the groups in all mRNA expressions
analyzed (ANOVA, all p#0.0254) except for GLUT3 mRNA (ANOVA, p=0.2). * indicates significant difference from astrocytes (Tukey Kramer post hoc
test p,0.05).
doi:10.1371/journal.pone.0021594.g001
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comparable range in all three cell types (figure 1 E). Nominally,
more GLUT2 mRNA than in adipocytes or myotubes was present
in astrocytes, but around 70-fold less than that found in HepG2
cells (figure 2 B). GLUT4 was barely detectable in astrocytes and
myotubes compared to adipocytes (figure 1 F).
At the protein level, we detected insulin receptor’s b-subunit, IRS-1,
Akt, and glycogen synthase kinase (GSK) 3 b in astrocytes (figure 3 A).
To investigate, if the insulin-signaling cascade is functional and can
thus be activated in human astrocytes, we performed a PI-3 kinase
assay. Following insulin stimulation, we found increased phosphor-
ylation of L-a-phosphatidylinositol towards phosphatidylinositol-39-
phosphate indicating increased PI-3 kinase activity. The insulin effect
was dose-dependent and could be detected at concentrations as low
as 1 nM (figure 3 C). Accordingly, Akt phosphorylation on serine 473
was increased by insulin stimulation, starting at concentration of
1 nM (figure 3 B). Increase in Akt phosphorylation and PI-3 kinase
activity reached statistical significance at 50 nM (figure 3 B and C).
Further on, we studied, whether metabolic functions of human
astrocytesareinfluenced byinsulin:glucose uptakeinto cellswasnot
affected by treatment with either 50 or 100 nM of insulin for 15
minutes (ANOVA p=0.7, N=5). Lactate content of the superna-
tants was neither influenced by stimulation with 50 nM insulin for
8 hours nor by variation of glucose concentration (figure 4).
However, when analyzing incorporation of labeled glucose into
glycogen, we detected a significant increase following insulin
stimulation. To test if this occurs via the classical PI-3 kinase/Akt
pathway, we added the PI-3 kinase inhibitor LY294002 and found
a significant decrease of glucose incorporation into glycogen of
around 30% under basal conditions, and insulin-stimulated
glycogen synthesis was abolished when LY294002 was added
(figure 5 A). Thus, basal glycogen synthesis as well as the insulin
effect on glycogen synthesis are PI-3 kinase-dependent.
We furthermore stained NHA cells for glycogen content before
and after stimulation with50 nM insulin for 3 h under two different
glucose concentrations, 1 g/l and 4.5 g/l. Whilst barely any of the
unstimulated cells contained detectable amounts of glycogen, some
of the insulin-stimulated cells stained positive for glycogen (figure 5
B). There were no detectable differences between the glucose
concentrations, neither in the stimulated nor in the unstimulated
cells (figure 5 B).
Finally, we investigated cell proliferation following insulin
treatment for three days by WST-1 assay. With increasing insulin
dose, there was an increase in dye formation that reached statistical
significance at a concentration of 50 nM (figure 6), indicating cell
proliferation. The morphology of the NHA cells did not appear
different between the insulin concentrations.
Discussion
In the present study, we could clearly demonstrate the presence
of major insulin signal transduction molecules in human primary
astrocytes. In addition, the insulin signaling cascade was shown to
be functionally active in these cells. We found insulin to stimulate
glycogen formation and cell proliferation, while glucose uptake
and lactate secretion were unaffected by the hormone.
Insulin receptor was present in comparable amounts as in the
other two tested insulin-sensitive cell types. Around two-thirds of
the insulin receptors in astrocytes were the receptor’s isoform A.
The expression of this isoform A in the human brain is well known
[24]. In contrast to isoform B, this isoform has, besides its binding
capacity for insulin, a high affinity for insulin-like growth factor 2
(IGF-2) [24]. Substantial amounts of IGF-2 are present in various
regions of the human brain [25] – effects on astrocytes have not
been studied in detail, yet. Furthermore, isoform A was found to
confer mitogenic responses [26]. In agreement, insulin induced
proliferation of astrocytes in our experiments.
Downstream of the insulin receptor, we detected both, IRS-1
and IRS-2 in human astrocytes. Both of them are important for
insulin signaling within the brain: Genetic variation within the
IRS-1 locus was shown to determine insulin responsiveness of the
human brain [27] and partially dysregulated IRS-2 signaling
causes hyperphagia and obesity in animals [28].
Figure 2. mRNA expression of insulin receptor isoforms A and B as well as GLUT 2 in human astrocytes. (A) mRNA expression of insulin
receptor isoform A and B in human astrocytes. Given are means + SEM, N=3. * = there were significant differences between groups (Student’s t-test,
p=0.0181). (B) mRNA expression of GLUT2 in human astrocytes (black bar), human myotubes (white bar), human adipocytes (dark grey bar), and
HepG2 (human hepatocellular carcinoma cell line, light grey bar). mRNA expression was normalized for mRNA of the housekeeping gene Rps13. Bars
represent means + SEM. N=3. There were significant differences between the groups (ANOVA, p=0.0006). * indicates significant difference from
astrocytes (Tukey Kramer post hoc test p,0.05).
doi:10.1371/journal.pone.0021594.g002
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GLUT1 and GLUT3 expressions, while only very little GLUT2
and almost no GLUT4 was detected. The first-mentioned two
transporters are insulin-independent, while GLUT4 is regulated
by insulin [29]. The expression pattern, hence, explains why we
could not detect any effect of insulin stimulation on astrocytes’
glucose uptake.
Even if expressed nearly ubiquitous [29], GLUT1 is believed to
be responsible for glucose transport across the blood-brain-barrier
[30], a structure to which astrocytes contribute [14,15]. The
importance of this transporter within the brain is underlined by rare
genetic defects within this gene causing cerebral damages [31].
While in cultured rat astrocytes GLUT3 expression was only
detectable after pretreatment with endotoxin or hypoxia [32], we
detected GLUT3 in primary human astrocytes even under basal
conditions. Since this transporter has a high glucose affinity [29],
it might possibly serve as the major glucose transporter in human
astrocytes.
In this study, we demonstrated the insulin signaling cascade to be
functional in terms of increased PI-3 kinase activity and Akt Serine
473 phosphorylation in these cells. Increments in PI-3 kinase
activity werealready detected at an insulinconcentration as lowas 1
nM, concentrations that are commonly exceeded in the blood of
healthy humans after food intake. Even if insulin concentrations in
the cerebrospinal fluid are markedly lower than those in the plasma
[33], astrocytes might be exposed to comparable concentrations in
vivo due to their close contact with blood vessels [14,15].
After characterizing human astrocytes as an insulin-responsive
cell type, we investigated whether these cells’ metabolic functions
are influenced by the hormone: similar to other glycogen-storing
cell types like hepatocytes or muscle cells, we found increased
glycogen storage in astrocytes following insulin stimulation. This
energy storage is important to support neurons with energy [10],
since neurons can not store glycogen for themselves. But neuronal
activity triggers the mobilization of astrocytes’ glycogen [34],
probably via the release of neurotransmitters [35]. This energy
Figure 3. Protein expression, insulin-stimulated Akt phosphorlyation, and insulin-stimulated phosphatidylinositiol 39-phosphor-
ylation in human astrocytes. (A) Equal amounts of total cell lysates of two independent experiments were loaded onto a SDS-PAGE gel. The
indicated proteins were detected using specific antibodies. (B) Cells were stimulated with the indicated insulin concentrations for 15 minutes and
lysed afterwards. Akt phosphorylation was detected by a phospho-specific antibody. A representative western blot is shown in the lower part. Bars in
the diagram represent means + SEM. N=6. There were significant differences between the groups (ANOVA, p=0.0108). * indicates significant
difference from 0 nM insulin (Tukey Kramer post hoc test p,0.05). (C) Following insulin stimulation with insulin for 30 minutes, cells were harvested,
and lysates were immunoprecipitated with anti IRS-1 antibodies and a PI-3 kinase assay was performed using L-a-phosphatidylinositol as substrate. A
representative image is shown in the lower part. Bars in the diagram represent means + SEM. N=3. There were significant differences between the
groups (ANOVA, p=0.0267). * indicates significant difference from 0 nM insulin (Tukey Kramer post hoc test p,0.05).
doi:10.1371/journal.pone.0021594.g003
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11,36]. Thus, larger glycogen stores in astrocytes due to insulin
action increase the rapidly available amount of energy and thus
might be permissive for stimulation of neuronal activation.
Thereby insulin-stimulated glycogen storage in astrocytes could
possibly contribute to insulin-mediated changes within the brain.
Surprisingly, when adding the PI-3-kinase inhibitor LY294002,
there was a marked decrease in glycogen synthesis even without
stimulation of the insulin signaling cascade. This points to an
endogenous activity of the PI-3-kinase/Akt pathway under basal
conditions that can, however, still be enhanced by insulin.
Whether basal, non-insulin-stimulated glycogen formation is
further regulated, and if so, what pathways or stimuli are involved
has not been studied yet.
By contrastto rodent astrocyte-enriched cultures, we did not detect
increment in lactate secretion after insulin stimulation, neither under
high nor under low glucose. Maybe the presence of neurons is
necessary to allow insulin to stimulate lactate secretion in human
astrocytes. To further investigate this question, experiments in co-
cultures of astrocytes and neurons are necessary.
We found cell numbers to increase after adding increasing insulin
concentrations in the medium for three days. This is in accordance to
previous findings in rodent astrocytes [19]. In humans, astrocytes are
among the brain cell types possessing the ability to proliferate in
adults. It is known that astrocyte numbers increase rapidly as part of
the reaction called astrogliosis (e.g. during inflammation or tissue
damage [37,38]). However, by light microscopy we did not detect
morphologiccharacteristicsofastrogliosis[38],i.e.hypertrophyofthe
cellbodyorprocesses.Theinsulinstimulatedincreaseincellnumbers
may thus be gliogenesis [39], another type of astrocyte proliferation
that takes place without those morphological changes. Gliogenesis
can occur in the adult brain and is stimulated by various cytokines
[39]. Therefore, insulin may be another inductor of astrocyte
p r o l i f e r a t i o ni nt h eh u m a nb r a i n .W h e t h e ra s t r o c y t en u m b e r sa r e
higher in persons with higher insulin levels (e.g. in obesity) has not
been studied. Our results point towards this possibility. Thus, this
would be worth to be further investigated especially because
differences in cerebral functions between lean and obese persons
have been found [27], but only little about underlying cellular
mechanisms has been revealed.
In conclusion, we characterized human astrocytes as an insulin-
responsive cell type in terms of glycogen formation and cell
proliferation. Hence, this cell type might contribute to the effects
of insulin in the human brain.
Methods
Cell culture
Normal Human Astrocytes (NHA) derived from fetal human
brain are commercially available as cryopreserved, primary-
derived cultures (Lonza, Basel, Switzerland). These cells are
guaranteed to stain positive for GFAP (Glial Fibrillary Acid
Protein), one marker for astrocytes. NHA were grown in AGM
medium (Lonza) containing 3% fetal bovine serum, 4.5% glucose,
and reagents from BulletKits (Lonza) in a humidified incubator at
37uC and 5% CO2. Prior to each experiment, cells were washed
twice with PBS (Lonza) and starved in DMEM (1 g/l glucose,
Lonza) +0.5% FCS for 48 h. The FCS used for our experiments
contains 54.9 ng/ml IGF-1. Since our starvation medium contains
0.5% FCS this results in a concentration of 0.27 ng/ml
(0.04 nmol/l) in the starvation medium. For insulin stimulation,
human recombinant insulin was used (Novo Nordisk, Bagsvard,
Denmark).
Human myotubes and adipocytes were grown from primary
precursor cells and differentiated in vitro as described earlier [40,41].
Human HepG2 hepatoma cells were grown in MEM medium
containing 10% FCS and 2 mM Glutamine until 80% confluence.
Western blot
The cells were lysed in lysis buffer containing 1% Triton X-100,
50 mM HEPES, pH 7.5, 10% glycerol, 150 mM NaCl, 1.5 mM
EGTA, 10 mM sodium pyrophosphate, 100 mM NaF, 2 mM
sodium orthovanadate, 10 mg/ml aprotinin, 1 mM phenylmethyl-
sulfonylfluoride. Lysates were cleared by centrifugation at 13,000 g
for 15 minutes at 4uC. After lysis, protein content was quantified
by Bradford’s method. Equal amounts of protein were loaded on
each lane of a SDS-PAGE (sodium dodecyl sulfate polyacrylamid
gel electrophoresis) gel. After run, proteins were transferred to a
nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany),
and incubated with the primary antibody mentioned below for one
hour. After three washes, the membranes were incubated with
secondary horseradish peroxidase-conjugated goat anti-mouse or
goat anti-rabbit antibodies (Sigma-Aldrich, St. Louis, MO, USA).
After three washes, detection was performed using the ECL system
(Amersham Life Science, Braunschweig, Germany). For quantifi-
cation of signal intensity of Western blots, the EasyWin32 Herolab
Software was used.
The following antibodies were used: Insulin receptor b-subunit
polyclonal antibodies from own production (detecting KKN GRI
LTL PRS NPS); IRS-1 antibodies (Millipore, Billerica, MA, USA);
Pan-Akt antibodies (R&D Systems, Minneapolis, MN, USA);
GSK3b antibodies (Cell Signaling, Danvers, MA, USA); Phospho-
Akt (Serine 473, Cell Signaling, Danvers, MA, USA).
Staining Glycogen was detected using the periodic acid-Schiff
(PAS) reaction. Mayer’s hemalum solution was used as a counterstain.
Glucose uptake
Cells were incubated in Krebs-Ringer-HEPES buffer for 3 hours.
Afterwards, they were stimulated with the indicated insulin
concentrations for 15 minutes. Following stimulation, a mixture of
2-deoxy-[1-
3H]-D-glucose (0.4 mCi/well) and 0.1 M non-labeled 2-
deoxyglucose was added for three minutes. The reaction was stopped
Figure 4. Effects of insulin stimulation and glucose concentra-
tion on lactate secretion of human astrocytes. Prior to
experiment, NHAs were either starved in medium containing 1 g/l
glucose or kept in medium with 4.5 g/l. Medium was than replaced by
new medium with the same glucose concentrations without (white
bars) or with 50 nM insulin (grey bars). After 8 hours, lactate
concentration in the supernatant was measured. Bars represent means
of five independent experiments + SEM. There were no significant
differences between groups (ANOVA, p=0.4).
doi:10.1371/journal.pone.0021594.g004
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were preincubated with the PI-3 kinase inhibitor LY294002 for 1 hour. Cells were stimulated with the indicated concentrations of insulin for 3 hours.
Glycogen synthesis in the absence of insulin and LY294002 was set as 100%. Bars represent means of at five independent experiments + SEM. There
were significant differences between the groups (ANOVA, p,0.0001). * indicates significant difference (Tukey Kramer post hoc test p,0.05). (B) Prior
to experiment, NHAs were either starved in medium containing 1 g/l glucose (left lane) or kept in medium with 4.5 g/l (right lane). Medium was than
replaced by new medium with the same glucose concentrations without (upper panels) or with 50 nM insulin (lower panels). After three hours of
stimulation, cells were stained for glycogen (pink). Shown are representative examples of at least three independent experiments.
doi:10.1371/journal.pone.0021594.g005
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lysed and analyzed with a beta-counter.
Lactate secretion
Cells were either starved in DMEM, 0.5% FCS, 1 g/l glucose or
kept in DMEM, 0.5% FCS, 4.5 g/l glucose for 48 h. Afterwards,
cells were stimulated with 50 nM of insulin for 48 hours or kept in
medium without insulin as a control. Lactate was quantified in the
supernatants using the lactate oxidase method with a commercial
colorimetric assay for ADVIA 1800 Clinical Chemistry System
(Siemens Medical Solutions, Eschborn, Germany).
PI-3 kinase assay
Lysates of normal human astrocytes were immunoprecipitated
with IRS-1 antibodies (Millipore, Billerica, MA, USA) and protein
A-coupled sepharose. After washing, the precipitates were incubat-
ed with 0.1 mg/ml L-a-phosphatidylinositol (Sigma Aldrich, St.
Louis,MO,USA) and 50 mM[ c
32P]-adenosinetriphosphate (Perkin
Elmer, Waltham, MA, USA) at room temperature for 10 minutes.
After adding 150 ml 1 M HCl, lipids were extracted using 450 ml
chloroform/methanol (1:1) twice. Products were separated by thin
layer chromatography.
32P-labeled phospholipids were detected by
autoradiography.
Glycogen synthesis
Cells were washed with pre-warmed PBS buffer twice and then
incubated in DMEM (0.5% FCS, 1 g/l glucose) at 37uC for
3 hours. Afterwards, they were stimulated with the indicated
insulin concentrations in DMEM medium containing
14C-D-
glucose (0.6 mCi/well; GE Healthcare, Little Chalfont, UK). After
three hours supernatant was discarded and the cells were washed
two times with ice-cold PBS. Afterwards, 500 ml KOH (30%) was
added onto the cells for 30 minutes at room temperature, until
cells were detached. Precipitation solution was than mixed with
1 mg of glycogen and boiled for 30 minutes at 95uC. Samples
were washed with ice-cold ethanol twice. Glycogen pellets were
resuspended in H2O and analyzed with a beta-counter.
Quantitative real-time RT-PCR
Cellswerewashedandharvestedbytrypsinisation.Cellswerelysed
with RLT and homogenized using QIAshredder (Qiagen, Hilden,
Germany). Total-RNA was isolated using RNeasy columns (Qiagen),
treated with RNase-free DNase I and transcripted to cDNA using
Transciptior First Strand cDNA Synthesis kit (Roche Diagnostics,
Mannheim, Germany). PCRs (in duplicates) were performed on a
LightCycler 480 (Roche Diagnostics) using Probes Master and
fluorescent probes from the Universal Probe Library (Roche
Diagnostics). The following real-time PCR protocol was used:
denaturation program (95uC for 5 minutes), an amplification and
quantification program repeated 45 times (95uC for 10 seconds, 60uC
for 30 seconds, 72uC for 1 second [fluorescence acquisition]), and
finally a cooling down program to 4uC. Primers were designed using
the Roche Probe Design 2 software (Roche Diagnositcs) and
purchased from TIB MOLBIOL (Berlin, Germany).
Insulin receptor isoform A was amplified using the following
primers: forward TTT CGT CCC CAG AAA AAC CTC T, reverse
CCACCGTCACATTCCCAAC. Insulin receptor isoform B was
amplified using primers: forward TTT TCG TCC CCA GGC CAT,
reverse CCA CCG TCA CAT TCC CAA C. Both reactions used 596-
FAM phosphoramidite-TCG CCA AGG GAC CTG CGT T-BBQ
(4,4-Bis-[2-butyloctyloxy]-p-quaterphenyl) as a probe.
The other reactions used standardRoche probes and the following
primers: Insulin receptor substrate (IRS)-1 forward GCC TAT GCC
AGC ATC AGT TT, reverse TTG CTG AGG TCA TTT AGG
TCT TC; IRS-2 forward TGA CTT CTT GTC CCA CCA CTT,
reverse CAT CCT GGT GAT AAA GCC AGA; insulin receptor
forward GCT GGA TTA TTG CCT CAA AGG, reverse TGA GAA
TCT TCA GAC TCG AAT GG; glucose transporter (GLUT) 1
forward GGT TGT GCC ATA CTC ATG ACC, reverse CAG ATA
GGA CAT CCA GGG TAG C; GLUT2 forward TGG TTT TCA
CTG CTG TCT CTG, reverse CAT TCC AAT TAG AAA GAG
AGA ACG TC; GLUT3 forward GCC CTG AAA GTC CCA GAT
TT, reverse TTC ATC TCC TGG ATG TCT TGG; GLUT4 forward
CTG TGC CAT CCT GAT GAC TG, reverse CGT AGC TCA
TGG CTG GAA CT, RPS13 forward CCC CAC TTG GTT GAA
GTT GA, reverse ACA CCA TGT GAA TCT CTC AGG A.
All RNA data is presented relative to the housekeeping gene
RPS13 using the DDCt method.
Cell proliferation assay
The water soluble tetrazolium (WST)-1 assay was used to
estimate astrocytes cell numbers according to the manufactur-
er’s instructions (Roche Molecular Biochemicals, Mannheim,
Germany). The amount of formazan dye formed directly
correlates to the number of metabolically active, viable cells.
Equal amounts of NHA were seeded in each well of a 96-well
plate. After starvation for at least 24 hours, cells were treated
with insulin for 3 days.
Statistical analyses
For all statistical analyses, the software package JMP 8.0.2 (SAS
Institute, Cary, NC, USA) was used. Two-group comparisons
were performed using Student’s t-test. Differences between
multiple groups were tested by ANOVA. Tukey–Kramer test
was used as a post-hoc test. Results with values of p#0.05 were
considered statistically significant.
Figure 6. Effects of insulin stimulation on human astrocytes’
proliferation. After starvation for at least 24 hours, cells were treated
with the indicated concentrations of insulin for 3 days. Thereafter, cell
proliferation was assessed by WST-1 assay. Bars represent means of six
independent experiments + SEM. There were significant differences
between the groups (ANOVA, p=0.0007). * indicates significant
difference from 0 nM (Tukey Kramer post hoc test p,0.05).
doi:10.1371/journal.pone.0021594.g006
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